Navigo Proteins GmbH

Navigo Proteins is a successful and steadily growing, privately held protein engineering company, which develops best-in-class custom precision affinity ligands, based on selected protein scaffolds. We partner with pharma, biotech and life science companies to build innovative biotherapeutics as well as provide next-generation custom affinity solutions for commercial biologics manufacturing based on our proprietary affinity ligands. Our outstanding protein engineering capabilities rely on our dedicated specialist team with in-depth expertise and a strong track record. Tailor-made targeting proteins for therapeutics and diagnostics, highly selective, stable, defined, proprietary affinity ligands, modularly combined with other function-conferring effector modules for building innovative biopharmaceutical drugs. Over 10,000 hospitals worldwide use radioisotopes for in-vivo diagnosis or treatment, reaching around 35 million patients each year.